Covered recipient · General Payments record
KEITH E EARLEY
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$3,357.91
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $668.22 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $215.20 | 7 |
| Alcon Laboratories Inc | $159.00 | 1 |
| ABBVIE INC. | $116.58 | 5 |
| RxSight Inc | $86.49 | 1 |
| Bausch & Lomb Americas Inc. | $44.21 | 2 |
| Tarsus Pharmaceuticals, Inc. | $29.00 | 1 |
| Thea Pharma Inc. | $17.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.64 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673112 | CMS |
| ABBVIE INC. | $22.64 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673114 | CMS |
| ABBVIE INC. | $19.96 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673116 | CMS |
| ABBVIE INC. | $32.89 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673118 | CMS |
| ABBVIE INC. | $25.45 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103673120 | CMS |
| Alcon Vision LLC | $159.00 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110568940 | CMS |
| Amgen Inc. | $16.78 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111567423 | CMS |
| Amgen Inc. | $16.91 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111567427 | CMS |
| Amgen Inc. | $121.63 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111567425 | CMS |
| Amgen Inc. | $18.61 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111567429 | CMS |
| Amgen Inc. | $1.26 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111567431 | CMS |
| Amgen Inc. | $18.37 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111567433 | CMS |
| Amgen Inc. | $21.64 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111567435 | CMS |
| Bausch & Lomb Americas Inc. | $20.62 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140384548 | CMS |
| Bausch & Lomb Americas Inc. | $23.59 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140384550 | CMS |
| RxSight Inc | $86.49 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144215921 | CMS |
| Tarsus Pharmaceuticals, Inc. | $29.00 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139094171 | CMS |
| Thea Pharma Inc. | $17.74 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074540617 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.